Daniel L. Swanson, BSChE, MBA, PE

IPS
Senior Process Specialist
Daniel (Dan) L. Swanson, PE is a Sr. Process Technologist at IPS-Integrated Project Services, LLC. IPS is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, construction management, and CQV of technically complex facilities worldwide. Mr. Swanson's role at IPS is focused on process and facility design for cell and gene therapy projects. He has helped clients navigate the complicated issues that surround cell and gene therapy projects such as multi-product segregation, small batch size, operator safety, manual manipulations, biosafety levels, and the need for future flexibility. While his focus is on the cell and gene therapy, Dan has worked on projects of all sizes across the biotech and pharmaceutical industries. His diverse background lends itself to project coordination and an emphasis on value-added design. He earned his bachelor's degree in chemical engineering from Michigan State University and his Master's in Business Administration at the NCSU Jenkins Graduate College of Management.

Related Articles

Design Considerations for Large-Scale Stem Cell Manufacturing
Features
Design Considerations for Large-Scale Stem Cell Manufacturing

There is much that large-scale commercial stem cell therapy processes can adopt from the existing bioprocessing industry. This article addresses some of the unique challenges posed by large-scale stem cell and stem cell–derived product manufacturing processes, and what should be considered while designing a manufacturing facility.

Figure 1: Cell therapy life cycles.
Features
Flexible Facility Design for Multiple Cell Therapy Processes

In many critical ways, the design of facilities for multiple cell therapy processes is unlike the design of conventional pharmaceutical facilities. This article surveys several of the key issues to consider when designing facilities capable of manufacturing multiple cell therapies, including regulatory definitions, product life cycles, processing systems, relevant cell therapy technologies and...